Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Innate Pharma S.A.

    NASDAQ: IPHA · Real-Time Price · USD
    2.11
    -0.07 (-3.21%)
    At close: Aug 15, 2025, 3:59 PM
    2.12
    0.47%
    After-hours: Aug 15, 2025, 04:00 PM EDT

    Innate Pharma S.A. Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 12.62M 51.9M 57.67M 12.11M
    Cost of Revenue
    		 n/a 56.02M 51.66M 47M
    Gross Profit
    		 12.62M -4.12M -2.02M -34.89M
    Operating Income
    		 -51.58M -12.67M -57.42M -47.83M
    Interest Income
    		 2.44M 3.18M 546K 327K
    Pretax Income
    		 -49.47M -7.57M -57.97M -45.48M
    Net Income
    		 -49.47M -7.57M -58.1M -59.14M
    Selling & General & Admin
    		 11.93M 11.75M 14.47M 25.52M
    Research & Development
    		 51.98M 56.02M 51.66M 47M
    Other Expenses
    		 283K -3.2M -8.04M -12.59M
    Operating Expenses
    		 64.2M 64.57M 66.06M 59.94M
    Interest Expense
    		 566K 640K 288K 312K
    Selling & Marketing Expenses
    		 n/a n/a n/a 9.53M
    Cost & Expenses
    		 64.2M 64.57M 107M 59.94M
    Income Tax Expense
    		 n/a n/a n/a 13.66M
    Shares Outstanding (Basic)
    		 81.05M 84.11M 79.59M 79.54M
    Shares Outstanding (Diluted)
    		 81.05M 84.11M 79.64M 79.54M
    EPS (Basic)
    		 -0.61 -0.09 -0.73 -0.74
    EPS (Diluted)
    		 -0.61 -0.09 -0.73 -0.74
    EBITDA
    		 -46.91M -1.84M -12.28M -43.23M
    EBIT
    		 -48.91M -6.93M -57.68M -45.17M
    Depreciation & Amortization
    		 1.99M 5.09M 45.41M 4.57M

    Add to Watchlist